SCHEMBL4774839

SCHEMBL4774839

CCC(CO)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 8/20 0.51
DYRK2 Q92630 7/20 0.51
DYRK1B Q9Y463 7/20 0.51
DYRK3 O43781 6/20 0.51
CDK5 Q00535 5/20 0.51
CCNA2 P20248 4/20 0.51
CDK2 P24941 4/20 0.51
CDK5R1 Q15078 4/20 0.51
CCNT1 O60563 3/20 0.51
CDK9 P50750 3/20 0.51
CYP2A6 P11509 1/20 0.46
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
FYN P06241 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4773536 0.88 CYP2A6 (0.44) CYP2A6NPC1TP53PKMTSHR
SCHEMBL4773513 0.88 CYP2A6 (0.44) CYP2A6NPC1TP53PKMTSHR
SCHEMBL4775017 0.88 CYP2A6 (0.44) CYP2A6NPC1TP53PKMTSHR
SCHEMBL4773182 0.85 CYP2A6 (0.39) DYRK1ADYRK2DYRK1BDYRK3CDK5
SCHEMBL4773165 0.85 CYP2A6 (0.39) DYRK1ADYRK2DYRK1BDYRK3CDK5
SCHEMBL4773489 0.84 CYP3A4 (0.39) DYRK1ADYRK2DYRK1BDYRK3CDK5
SCHEMBL3962124 0.83 CYP2A6 (0.46) CYP2A6NPC1TP53PKMTSHR
SCHEMBL4766379 0.83 CYP2A6 (0.46) CYP2A6NPC1TP53PKMTSHR
SCHEMBL4766345 0.83 CYP2A6 (0.46) CYP2A6NPC1TP53PKMTSHR
SCHEMBL25458367 0.81 DYRK1A (0.48) DYRK1ADYRK2DYRK1BDYRK3CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed